In accordance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 and based on the certificates received from KFin Technologies (Formerly known as KFin Technologies) [Registrar and Share Transfer Agent], Laurus Labs has confirmed that no requests received from depository participants for dematerialization of securities during the quarter ended December 31, 2022.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1663.10 |
| Dr. Reddys Lab | 1224.45 |
| Cipla | 1235.20 |
| Zydus Lifesciences | 929.25 |
| Lupin | 2310.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: